GLP-1/GIP is a dual-action metabolic therapy that works with your body’s natural hormones to improve appetite control, stabilize blood sugar, and support long-term weight loss. It enhances both satiety and metabolic efficiency for stronger, more sustained results.

GLP-1/GIP slows gastric emptying, reduces cravings, balances blood sugar, and helps you feel full faster and longer. This leads to reduced caloric intake, improved energy levels, and consistent weight-loss progress week after week.

It is available as a weekly subcutaneous injection or daily oral drops. Both options are designed for convenience and gradual, steady metabolic improvement.

Both forms support appetite regulation and metabolic health. Injections may offer stronger, more consistent absorption, while oral drops provide a needle-free option that fits easily into daily routines.

Most patients begin noticing reduced cravings and improved appetite control within 1–2 weeks, with visible weight-loss results typically appearing around 4–6 weeks. Full benefits continue building over several months.

Patients often experience more stable energy, improved digestion, better sleep, reduced inflammation, and enhanced overall metabolic health. Balanced blood sugar can also support clearer thinking and fewer mid-day crashes.

The most common side effects are mild nausea, decreased appetite, constipation, or bloating — usually temporary as your body adjusts. Slow dose titration helps minimize discomfort.

Yes. When monitored by licensed providers, GLP-1/GIP is considered safe and effective. Regular check-ins ensure dosing is optimized and well-tolerated.

Yes. GLP-1/GIP works well alongside peptides, TRT/HRT, NAD+, and other metabolic support treatments. A provider will build a personalized plan based on your goals.